Bristol-Myers Squibb Company
Company Income Statement
| Dec 2007 | Dec 2006 | Dec 2005 | Dec 2004 | |
| Sales | 19.35B | 17.91B | 19.21B | 19.38B |
| Cost of Sales | 5.33B | 5.03B | 5.00B | 5.08B |
| Gross Operating Profit | 14.02B | 12.88B | 14.21B | 14.30B |
| Selling, General, and Administrative Expenses | 3.28B | 3.07B | 2.75B | 2.50B |
| Research & Development | 4.86B | 4.92B | 5.11B | 5.02B |
| Operating Income before D & A (EBITDA) | 4.42B | 3.55B | 4.88B | 5.37B |
| Depreciation & Amortization | 892.00M | 927.00M | 929.00M | 909.00M |
| Interest Income | 241.00M | 274.00M | 148.00M | 105.00M |
| Other Income - Net | -183.00M | 125.00M | 733.00M | 473.00M |
| Special Income / Charges | -14.00M | -302.00M | -269.00M | -420.00M |
| Total Income Before Interest Expenses (EBIT) | 3.96B | 3.13B | 4.86B | 4.73B |
| Interest Expense | 422.00M | 498.00M | 349.00M | 310.00M |
| Pre-Tax Income | 3.53B | 2.64B | 4.52B | 4.42B |
| Income Taxes | 803.00M | 610.00M | 932.00M | 1.52B |
| Minority Interest | 763.00M | 440.00M | 592.00M | 521.00M |
| Net Income From Continuing Operations | 1.97B | 1.58B | 2.99B | 2.38B |
| Net Income From Discontinued Operations | 197.00M | 0.00 | 8.00M | 10.00M |
| Net Income From Total Operations | 2.16B | 1.58B | 3.00B | 2.39B |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 2.16B | 1.58B | 3.00B | 2.39B |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
2.12B | 1.95B | 3.29B | 2.96B |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 1.97B | 1.58B | 2.99B | 2.38B |
| Basic EPS from Continuing Ops. | 1.00 | 0.81 | 1.53 | 1.23 |
| Basic EPS from Discontinued Ops. | 0.10 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 1.10 | 0.81 | 1.53 | 1.23 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 1.10 | 0.81 | 1.53 | 1.23 |
| Basic Normalized Net Income/Share | 1.08 | 0.99 | 1.68 | 1.53 |
| EPS fr Continuing Ops. | 0.99 | 0.81 | 1.52 | 1.21 |
| EPS fr Discontinued Ops | 0.10 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 1.09 | 0.81 | 1.52 | 1.21 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 1.09 | 0.81 | 1.52 | 1.21 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.07 | 0.99 | 1.67 | 1.51 |
| Dividends Paid per Share | 1.12 | 1.12 | 1.12 | 1.12 |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas